NFSG
ATYR

Newbridge Financial Services Group’s aTyr Pharma ATYR Stock Holding History

Newbridge Financial Services Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Sell
1,979
-100
-5% -$65 ﹤0.01% 1118
2026
Q1 		$1.62K Sell
2,079
-1,521
-42% -$1.28K ﹤0.01% 1041
2025
Q4 		$2.82K Buy
3,600
+3,100
+620% +$2.54K ﹤0.01% 982
2025
Q3 		$361 Hold
500
– – ﹤0.01% 1230
2025
Q2 		$2.54K Buy
+500
New +$1.97K ﹤0.01% 1117

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Newbridge Financial Services Group's ATYR Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its aTyr Pharma (ATYR) stake by 4.8% in Q2 2026, selling an estimated $65 and leaving 1,979 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

Newbridge Financial Services Group first reported a position in ATYR in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.82K in Q4 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Newbridge Financial Services Group held 1,979 shares of aTyr Pharma worth $1.18K as of Q2 2026.
  • Newbridge Financial Services Group sold 100 aTyr Pharma shares in Q2 2026, an estimated $65.
  • aTyr Pharma made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1118 holding.
  • Newbridge Financial Services Group first reported a position in aTyr Pharma in Q2 2025 and has held it in 5 quarters since.
  • Newbridge Financial Services Group's aTyr Pharma position peaked at $2.82K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.